Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-09

Clinical Trial Update: To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of co-administered ezetimibe/rosuvastatin with telmisartan in patients with essential hypertension a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ezetimibe/Rosuvastatin (ezetimibe/rosuvastatin)
  • Telmisartan (Telmisartan)

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Primary Hypercholesterolemia, Hypertension | Phase 3 | Status: UNKNOWN